. 1/2019. 2. Approved the appropriation and retaining of the net profit Baht 511 million as legal reserve and the declaration of dividend payment from the Company consolidated net profit for the period

Performance for the year ended December 31, 2018 business of the Company due to the increase of cost of program right which was invested during the period to support the business growth. In addition, the

than last year. Credit Card receivable was 418,747 million baht, with the growth of 6% from the same period last year. For personal loan industry, the numbers of account of personal loan under

operating activities 1,788 Net cash flows investing activities (2,101) Net cash flows financing activities 623 Net increase in cash and cash equivalents 310 Cash and cash equivalents at beginning of period

financial period, net cash was increased by 12.24 million Baht. This comprised of the following items: 1) Net cash received from Operating Activities totaling Baht 594.40 million Baht from the net income by

. The average collection period as at the end of this quarter was 95 days compared to 139 days as of 31 December 2018. The increase in average collection period was because of Trans.Ad Group ‘s

CMG revenues when goods are ready for transfer to customers (precisely after incubation period) and not when it has been transferred. This impacted the Company and its subsidiaries’ financial statement

recognize CMG revenues when goods are ready for transfer to customers (precisely after incubation period) and not when it has been transferred. This impacted the Company and its subsidiaries’ financial

Limited for the three months period ended March 31, 2019. And The Audited financial statement of BS Myco Biotech Company Limited for year ended December 31,2018. The calculation of transaction size (1) Book

the period ended (Kiosk) 129,948 130,109 130,053 129,208 129,011 Total average number of money transfer transactions (per day) 27,287 28,689 30,006 30,553 31,813 In 2Q19, FSMART is able to maintain as